These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 909055)

  • 1. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
    Martz F; Failinger C; Blake DA
    J Pharmacol Exp Ther; 1977 Oct; 203(1):231-9. PubMed ID: 909055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin enhances epoxide metabolism in human fetal liver cultures.
    Rane A; Peng D
    Drug Metab Dispos; 1985; 13(3):382-5. PubMed ID: 2862003
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophen.
    Lum JT; Wells PG
    Teratology; 1986 Feb; 33(1):53-72. PubMed ID: 3738810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of teratogens on maternal corticosterone levels and cleft incidence in A/J mice.
    Sullivan-Jones P; Hansen DK; Sheehan DM; Holson RR
    J Craniofac Genet Dev Biol; 1992; 12(4):183-9. PubMed ID: 1494023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol.
    Wells PG; Küpfer A; Lawson JA; Harbison RD
    J Pharmacol Exp Ther; 1982 Apr; 221(1):228-34. PubMed ID: 7062285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin.
    Tiboni GM; Iammarrone E; Giampietro F; Lamonaca D; Bellati U; Di Ilio C
    Teratology; 1999 Feb; 59(2):81-7. PubMed ID: 10069438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the teratogenic properties manifested in BALB c mice, by diphenylhydantoin and deuterated diphenylhydantoin].
    Lambotte-Vandepaer M; Brams A; Crutzen-Fayt MC; Duverger-Van Bogaert M; Dumont P; Léonard A
    C R Seances Soc Biol Fil; 1989; 183(4):358-61. PubMed ID: 2533521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-1 mouse fetus.
    Eluma FO; Sucheston ME; Hayes TG; Paulson RB
    J Craniofac Genet Dev Biol; 1984; 4(3):191-210. PubMed ID: 6438150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen.
    Hinson JA; Pohl LR; Monks TJ; Gillette JR; Guengerich FP
    Drug Metab Dispos; 1980; 8(5):289-94. PubMed ID: 6107223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
    Wong M; Helston LM; Wells PG
    Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of delta 9-tetrahydrocannabinol-induced teratogenicity by stimulation and inhibition of its metabolism.
    Harbison RD; Mantilla-Plata B; Lubin DJ
    J Pharmacol Exp Ther; 1977 Aug; 202(2):455-65. PubMed ID: 886474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin embryopathy: effect of epoxide hydrolase inhibitor on phenytoin exposure in utero in C57BL/6J mice.
    Hartsfield JK; Holmes LB; Morel JG
    Biochem Mol Med; 1995 Dec; 56(2):131-43. PubMed ID: 8825076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis.
    Finnell RH; Buehler BA; Kerr BM; Ager PL; Levy RH
    Neurology; 1992 Apr; 42(4 Suppl 5):25-31. PubMed ID: 1574173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of phenytoin in teratogenesis-susceptible and -resistant strains of mice.
    Hansen DK; Hodes ME
    Drug Metab Dispos; 1983; 11(1):21-4. PubMed ID: 6132790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.
    Roy D; Snodgrass WR
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of styrene oxide in different human fetal tissues.
    Pacifici GM; Rane A
    Drug Metab Dispos; 1982; 10(4):302-5. PubMed ID: 6126324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin metabolism in mice.
    Chow SA; Fischer LJ
    Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
    Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH
    Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
    Gordon GB; Spielberg SP; Blake DA; Balasubramanian V
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2545-8. PubMed ID: 6941308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
    Lu LJ; Disher RM; Reddy MV; Randerath K
    Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.